CCM
NUVA

Channing Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Channing Capital Management’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,179,211
Closed -$48.6M – 122
2022
Q4 		$48.6M Sell
1,179,211
-71,535
-6% -$2.9M 1.55% 36
2022
Q3 		$54.8M Sell
1,250,746
-81,792
-6% -$3.96M 1.89% 24
2022
Q2 		$65.5M Buy
1,332,538
+163,613
+14% +$8.78M 2.14% 16
2022
Q1 		$66.3M Buy
1,168,925
+119,121
+11% +$6.33M 1.95% 21
2021
Q4 		$55.1M Buy
1,049,804
+131,537
+14% +$7.15M 1.56% 31
2021
Q3 		$55M Buy
918,267
+109,225
+14% +$6.73M 1.71% 28
2021
Q2 		$54.8M Buy
809,042
+153,016
+23% +$10.4M 1.81% 19
2021
Q1 		$43M Buy
656,026
+61,227
+10% +$3.67M 1.47% 30
2020
Q4 		$33.5M Buy
+594,799
New +$29.3M 1.36% 38

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Channing Capital Management's NUVA Position: Q1 2023 in Review

Channing Capital Management sold out of NuVasive, Inc. (NUVA) in Q1 2023, closing a stake of 1,179,211 shares — an estimated $48.6M sold.

Channing Capital Management first reported a position in NUVA in Q4 2020 and held it in 9 quarters. The position peaked at $66.3M in Q1 2022. 240 funds tracked by Wall St. Rank hold NUVA as of Q1 2023.

  • Channing Capital Management reported no remaining NuVasive, Inc. position as of Q1 2023 after selling out during the quarter.
  • Channing Capital Management sold 1,179,211 NuVasive, Inc. shares in Q1 2023, an estimated $48.6M.
  • Channing Capital Management first reported a position in NuVasive, Inc. in Q4 2020 and held it in 9 quarters.
  • Channing Capital Management's NuVasive, Inc. position peaked at $66.3M in Q1 2022.
  • 240 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2023.

Based on Channing Capital Management's 13F filing for Q1 2023, filed 9 May 2023.